Rocket Pharmaceuticals RCKT
NASDAQ RCKT
$2.40 -0.08 (-3.23%)
As of: Nov 12, 2026 · 9:38 AM EST

Rocket Pharmaceuticals (RCKT) Return on Capital Employed [ROCE] (2015 - 2026)

Updated

Rocket Pharmaceuticals (RCKT) reported Return on Capital Employed [ROCE] of -59.34% for Q2 2026, up 7.13 percentage points from -66.48% a year earlier and up 16.81 percentage points from the prior quarter.

Analysis

Rocket Pharmaceuticals (RCKT) Return on Capital Employed [ROCE] (2015 - 2026) Analysis & Trends

For FY2025, Rocket Pharmaceuticals posted Return on Capital Employed [ROCE] of -58.10%, down 4.14 percentage points from FY2024.

  • Return on Capital Employed [ROCE] has declined for six consecutive years, with a five-year change of -28.18 percentage points (FY2020 to FY2025).
  • By year, Return on Capital Employed [ROCE] came in at -53.96% in FY2024 (-3.10 pp), -50.86% in FY2023 (-4.62 pp), -46.23% in FY2022 (-14.18 pp) and -32.05% in FY2021 (-2.13 pp).
  • The Q2 2026 figure ranks as the highest quarterly Return on Capital Employed [ROCE] since Q1 2025.
  • Year over year, Return on Capital Employed [ROCE] gained in two of the last eight quarters, with an average year-over-year change of -7.51 percentage points.
  • The high point for year-over-year Return on Capital Employed [ROCE] in five years was Q2 2026 (a gain of 7.13 percentage points); the low point was Q3 2024 (a drop of 18.60 percentage points).
  • Per Business Quant data, the three quarters before Q2 2026 came in at -76.15% (Q1 2026), -72.64% (Q4 2025) and -68.94% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 35.41%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 17.52%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 21.60%
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 4.65%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 9.91%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 17.37%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -6.15%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 11.32%
10 Rocket Pharmaceuticals 268.37 Mn -15.33 Mn - -59.34%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -59.34%
Mar 31, 2026 -76.15%
Dec 31, 2025 -72.64%
Sep 30, 2025 -68.94%
Jun 30, 2025 -66.48%
Mar 31, 2025 -58.23%
Dec 31, 2024 -65.05%
Sep 30, 2024 -72.04%
Jun 30, 2024 -61.97%
Mar 31, 2024 -52.97%
Dec 31, 2023 -48.62%
Sep 30, 2023 -53.43%
Jun 30, 2023 -56.95%
Mar 31, 2023 -48.59%
Dec 31, 2022 -50.37%
Sep 30, 2022 -50.61%
Jun 30, 2022 -45.23%
Mar 31, 2022 -37.41%
Dec 31, 2021 -34.03%
Sep 30, 2021 -35.84%
API Access

Rocket Pharmaceuticals Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=RCKT&period=max&api_key=YOUR_API_KEY